INO
INO
NASDAQ · Biotechnology

Inovio Pharmaceuticals Inc

$1.43
-0.03 (-2.05%)
Day Range $1.39 — $1.48
52W Range $0.56 — $2.72
Open$1.44
Previous Close$1.46
Day High$1.48
Day Low$1.39
52W High$2.72
52W Low$0.56
Volume—
Avg Volume48.84M
Market Cap273.47M
P/E Ratio—
EPS$-1.17
SectorBiotechnology

Analyst Ratings

Buy
7 analysts
5 Buy 2 Hold 0 Sell
Price Target +1,271.3% upside
Current
$1.43
Target
$19.61
$14.26 $19.61 avg $29.32

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 315.1K 1.70M 29.02M
Net Income -407,771,247 -1,980,540,325 -227,719
Profit Margin -130,006.0% -123,505.7% -0.8%
EBITDA -409,976,998 -2,101,878,834 -290,155
Free Cash Flow — — -255,634
Rev Growth -81.5% -81.5% +16.9%
Debt/Equity — — 0.72

Biotechnology Peers

Symbol Name Price Change P/E Mkt Cap
ABBV Abbvie Inc $294.55 -0.16% 50.3 520.47B
AMGN Amgen Inc $456.60 -1.24% 26.9 252.64B
GILD Gilead Sciences Inc $169.42 +1.10% — 208.95B
VRTX Vertex Pharmaceuticals Inc $531.97 -1.08% 33.9 134.82B
REGN Regeneron Pharmaceuticals $951.08 -0.14% 20.4 98.38B
ALNY Alnylam Pharmaceuticals Inc $159.73 -3.22% 7.7 20.98B

INO News

No news for INO yet

Quick Stats

Market Cap273.47M
P/E Ratio—
EPS$-1.17
Volume—
SectorBiotechnology